Vol 2, No 5 (October 22, 2013): Translational Lung Cancer Research (Management of early stage non-small cell lung cancer - Guest Editor: Heather Wakelee)

Management of early stage non-small cell lung cancer

Interventional pulmonology approaches in the diagnosis and treatment of early stage non small cell lung cancer

Alternatives to surgery in early stage disease—stereotactic body radiotherapy

Alternative to surgery in early stage NSCLC—interventional radiologic approaches

Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?

Towards optimal pathologic staging of resectable non-small cell lung cancer

Prognostic and predictive biomarkers in early stage non-small cell lung cancer: tumor based approaches including gene signatures

Prognostic and predictive biomarkers in early stage NSCLC: CTCs and serum/plasma markers

Neoadjuvant chemotherapy in early-stage non-small cell lung cancer

Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC)

Adjuvant molecularly targeted therapy—epidermal growth factor tyrosine kinase inhibition and beyond

Anti-tumor immune response in early stage non small cell lung cancer (NSCLC): implications for adjuvant therapy

Post-operative radiation therapy